Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients-Reference-Cited by-同舟云学术

Efficacy and safety of biologics and small molecules for psoriasis in pediatric and geriatric populations. Part I: focus on pediatric patients

Published:2023-01-02 Issue:1 Volume:22 Page:25-41
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Megna Matteo¹^ORCID,Camela Elisa¹^ORCID,Battista Teresa¹,Genco Lucia¹,Martora Fabrizio¹,Noto Matteo¹,Picone Vincenzo¹,Ruggiero Angelo¹^ORCID,Monfrecola Giuseppe¹,Fabbrocini Gabriella¹^ORCID,Potestio Luca¹^ORCID

Affiliation:

1. Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2173170

Reference87 articles.

1. Psoriasis: epidemiology

2. Treating psoriasis in the elderly: biologics and small molecules

3. Childhood psoriasis

4. Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities

5. Epidemiology and clinical features of pediatric psoriasis in tertiary referral psoriasis clinic

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Injection site reactions resulting from the use of biological therapy in the treatment of moderate-to-severe plaque psoriasis;Expert Opinion on Drug Safety;2024-08-17

2. Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond;Expert Opinion on Pharmacotherapy;2024-06-12

3. Efficacy and safety of deucravacitinib for the management of psoriasis: a drug safety evaluation;Expert Opinion on Drug Safety;2024-05-06

4. Management of Psoriasis Patients with Serious Infectious Diseases;Advances in Therapy;2024-05-06

5. The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials;Clinical, Cosmetic and Investigational Dermatology;2024-04